Altered profiles in nuclear matrix proteins associated with DNA in Situ during progression of breast cancer cells

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1362-1366

  Spencer, Virginia A ^a   Samuel, Shanti K ^a   Davie, James R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; BIOLOGICAL MARKER; CELL NUCLEUS DNA; CISPLATIN; ESTROGEN RECEPTOR; NUCLEAR PROTEIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CELL NUCLEUS MATRIX; CHROMATIN; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN RNA BINDING; TUMOR CELL LINE; TUMOR GROWTH; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIGENS, NUCLEAR; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CISPLATIN; DISEASE PROGRESSION; DNA, NEOPLASM; DNA-BINDING PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035866410     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. The etiology of breast cancer - From epidemiology to prevention
2. Incidence of and treatment for ductal carcinoma in situ of the breast
3. Endocrine treatment of advanced breast cancer
4. The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs
5. Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies
6. Oestrogen receptor: A stable phenotype in breast cancer
7. Steroid receptors and other prognostic factors in primary breast cancer
8. The utilization of nuclear matrix proteins for cancer diagnosis
9. Role of the nuclear matrix in breast cancer
10. Association of chromosome territories with the nuclear matrix
11. The cellular organization of gene expression
12. Nuclear neighbors: The spatial and functional organization of genes and nuclear domains
13. Functional subnuclear partitioning of transcription factors
14. Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: The C-terminus is a principal determinant for nuclear trafficking
15. Intranuclear targeting of AML/CBFα regulatory factors to nuclear matrix-associated transcriptional domains
16. Organization of highly acetylated chromatin around sites of heterogeneous nuclear RNA accumulation
17. The new paradigm: Integrating genomic function and nuclear architecture
18. Changes in the nuclear matrix of chicken erythrocytes that accompany maturation
19. Chromatin, nuclear matrix, and the cytoskeleton: Role of cell structure in neoplastic transformation
20. Nuclear dreams: The malignant alteration of nuclear architecture
21. Nuclear matrix proteins in normal and breast cancer cells
22. Nuclear matrix proteins in human colon cancer
23. Human cervical cancer-associated nuclear matrix proteins
24. Identification of nuclear matrix proteins in the cancer and normal rat prostate
25. Bladder cancer-associated nuclear matrix proteins
26. Unique nuclear matrix protein alterations in head and neck squamous cell carcinomas: Intermediate biomarker candidates
27. Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines
28. Differentiation-specific nuclear matrix proteins cross-linked to DNA by cis-diamminedichloroplatinum
29. Differential crosslinking of histones and non-histones in nuclei by cis- Pt(II)
30. Binding of cis- and trans-dichlorodiammineplatinum(II) to the nucleosome core
31. In situ cross-linking by cisplain of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells
32. Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells
33. Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines
34. MCF7/LCC2: A 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780
35. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications
36. Nuclear matrix: Application to diagnosis of cancer and role in transcription and modulation of chromatin structure
37. Altered nuclear matrix protein profiles in oncogene transformed fibroblasts exhibiting high metastatic potential
38. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development
39. Nuclear matrix proteins and their potential applications to diagnostic pathology
40. The nuclear envelope, muscular dystrophy, and gene expression
41. Association of DNase sensitive chromatin domains with the nuclear periphery in 3T3 cells in vitro
42. Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells